Toward the total synthesis of spirastrellolide A. Part 1: Strategic considerations and preparation of the southern domain

Angewandte Chemie - International Edition

Volumn 45, Issue 33, 2006, Pages 5506-5510

  Fürstner, Alois ^a   Fenster, Michaël D B ^a   Fasching, Bernhard ^a   Godbout, Cédrickx ^a   Radkowski, Karin ^a  

^a MAX PLANCK INSTITUT FÜR KOHLENFORSCHUNG   (Germany)

Author keywords

Antitumor agents; Macrolides; Natural products; Phosphatase inhibitors; Total synthesis

Indexed keywords

ANTITUMOR AGENTS; MACROLIDES; NATURAL PRODUCTS; PHOSPHATASE INHIBITORS; TOTAL SYNTHESIS;

CHLORINATION; ENZYME INHIBITION; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

DRUG PRODUCTS;

ANTINEOPLASTIC AGENT; MACROLIDE; SPIRASTRELLOLIDE A;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; METABOLISM; SPONGE (PORIFERA); SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; MACROLIDES; MOLECULAR STRUCTURE; PORIFERA;

EID: 33748661293     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200601654     Document Type: Article

References (49)

1. D. E. Williams, M. Roberge, R. Van Soest, R. J. Andersen, J. Am. Chem. Soc. 2003, 125, 5296-5297.
2. D. E. Williams, M. Lapawa, X. Feng, T. Tarling, M. Roberge, R. J. Andersen, Org. Lett. 2004, 6, 2607-2610.
3. Recent reviews on phosphatases as targets for medicinal chemistry: a) L. Bialy, H. Waldmann, Angew. Chem. 2005, 117, 3880-3906;
4. Angew. Chem. Int. Ed. 2005, 44, 3814-3839;
5. b) A. McCluskey, A. T. R. Sim, J. A. Sakoff, J. Med. Chem. 2002, 45, 1151-1175;
6. c) R. E. Honkanen, T. Golden, Curr. Med. Chem. 2002, 9, 2055-2075.
7. For studies toward 1 reported by other groups, see: a) I. Paterson, E. A. Anderson, S. M. Dalby, O. Loiseleur, Org. Lett. 2005, 7, 4121-4224;
8. b) I. Paterson, E. A. Anderson, S. M. Dalby, O. Loiseleur, Org. Lett. 2005, 7, 4125-4128;
9. c) J. Liu, R. P. Hsung, Org. Lett. 2005, 7, 2273-2276;
10. d) Y. Pan, J. K. DeBrabander, Synlett 2006, 853-856;
11. e) for an approach toward the originally proposed structure, see: I. Paterson, E. A. Anderson, S. M. Dalby, Synthesis 2005, 3225-3228.
12. a) T. M. Trnka, R. H. Grubbs, Acc. Chem. Res. 2001, 34, 18-29;
13. b) A. Fürstner, Angew. Chem. 2000, 112, 3140-3172;
14. Angew. Chem. Int. Ed. 2000, 39, 3012-3043.
15. A. Fürstner, M. D. B. Fenster, B. Fasching, C. Godbout, K. Radkowski, Angew. Chem. 2006, 118, 5636-5641;
16. Angew. Chem. Int. Ed. 2006, 45, 5510-5515.
17. Note that a late-stage fragment coupling between the northern and the southern domain at C25/C26 by metathesis (or other suitable olefination reactions) is envisaged (cf. Scheme 2); a selective hydrogenation of this newly formed alkene in the presence of a pre-existing Z olefin at C15/C16 might raise serious selectivity issues.
18. H. C. Brown, K. S. Bhat, J. Am. Chem. Soc. 1986, 108, 293-294.
19. U. P. Dhokte, V. V. Khau, D. R. Hutchison, M. J. Martinelli, Tetrahedron Lett. 1998, 39, 8771-8774.
20. H. Iida, N. Yamazaki, C. Kibayashi, J. Org. Chem. 1987, 52, 3337-3342.
21. a) C. S. Poss, S. L. Schreiber, Acc. Chem. Res. 1994, 27, 9-17;
22. b) for an example from our group, see: A. Fürstner, M. Albert, J. Mlynarski, M. Matheu, E. DeClercq, J. Am. Chem. Soc. 2003, 125, 13 132-13 142.
23. a) U. S. Racherla, H. C. Brown, J. Org. Chem. 1991, 56, 401-404;
24. b) U. S. Racherla, Y. Liao, H. C. Brown, J. Org. Chem. 1992, 57, 6614-6617;
25. c) H. C. Brown, P. K. Jadhav, J. Am. Chem. Soc. 1983, 105, 2092-2093.
26. a) M. Ide, M. Nakata, Bull. Chem. Soc. Jpn. 1999, 72, 2491-2499;
27. b) reviews: D. Seebach, Synthesis 1969, 17-36;
28. c) M. Yus, C. Nájera, F. Foubelo, Tetrahedron 2003, 59, 6147-6212;
29. d) A. B. Smith, S. M. Condon, J. A. McCauley, Acc. Chem. Res. 1998, 31, 35-46.
30. S. D. Meyer, S. L. Schreiber, J. Org. Chem. 1994, 59, 7549-7552.
31. A. J. Mancuso, D. Swern, Synthesis 1981, 165-185.
32. a) L. Weiler, J. Am. Chem. Soc. 1970, 92, 6702-6704;
33. b) S. N. Huckin, L. Weiler, J. Am. Chem. Soc. 1974, 96, 1082-1087.
34. R. Noyori, T. Okhuma, M. Kitamura, H. Takaya, N. Sayo, H. Kumobayashi, S. Akutagawa, J. Am. Chem. Soc. 1987, 109, 5856-5858.
35. a) S. A. King, A. S. Thompson, A. O. King, T. R. Verhoeven, J. Org. Chem. 1992, 57, 6689-6691;
36. b) A. Fürstner, T. Dierkes, O. R. Thiel, G. Blanda, Chem. Eur. J. 2001, 7, 5286-5298, and references therein.
37. Review: T. Ohkuma, R. Noyori in Comprehensive Asymmetric Catalysis, Vol. 1 (Eds.: E. N. Jacobsen, A. Pfaltz, H. Yamamoto), Springer, Berlin, 1999, pp. 199-246.
38. a) D. A. Evans, M. J. Dart, J. L. Duffy, M. G. Yang, J. Am. Chem. Soc. 1996, 118, 4322-4343;
39. b) review: T. Mukaiyama, Org. React. 1982, 28, 203-331.
40. For pertinent examples of 1,5-anti stereoinduction in boron aldol chemistry as required in the present case, see: a) D. A. Evans, B. Côté, P. J. Coleman, B. T. Connell, J. Am. Chem. Soc. 2003, 125, 10 893-10 898;
41. b) D. A. Evans, P. J. Coleman, B. Coté, J. Org. Chem. 1997, 62, 788-789;
42. c) I. Paterson, K. R. Gibson, R. M. Oballa, Tetrahedron Lett. 1996, 37, 8585-8588;
43. d) for examples using β-tetrahydropyranyl methyl ketones, see: D. A. Evans, D. M. Fitch, T. E. Smith, V. J. Cee, J. Am. Chem. Soc. 2000, 122, 10 033-10 046;
44. e) M. T. Crimmins, P. Siliphaivanh, Org. Lett. 2003, 5, 4641-4644;
45. f) S. A. Kozmin, Org. Lett. 2001, 3, 755-758.
46. A series of control experiments and detailed analyses of the Mosher esters confirmed the proposed stereochemical assignments; details will be reported in a forthcoming report.
47. D. A. Evans, K. T. Chapman, E. M. Carreira, J. Am. Chem. Soc. 1988, 110, 3560-3578.
48. T. Ichige, A. Miyake, N. Kanoh, M. Nakata, Synlett 2004, 1686-1690.
49. Comparison of the NMR data of the individual isomers (see the Supporting Information) with the reported data of 1, however, do not allow us to decide which relative configuration is present in the natural product.